ATEC
Alphatec Holdings, Inc. NASDAQ Listed Jun 12, 2006$7.75
Mkt Cap $1.2B
52w Low $6.85
5.4% of range
52w High $23.29
50d MA $11.52
200d MA $15.37
P/E (TTM)
-10.9x
EV/EBITDA
-91.1x
P/B
43.4x
Debt/Equity
17.2x
ROE
-1153.7%
P/FCF
1137.4x
RSI (14)
—
ATR (14)
—
Beta
1.12
50d MA
$11.52
200d MA
$15.37
Avg Volume
2.7M
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
1950 Camino Vida Roble · Carlsbad, CA 92008 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.01 | -0.22 | -2100.0% | 10.23 | -21.7% | -31.7% | -24.2% | — | — | — | — |
| Feb 24, 2026 | AMC | 0.04 | 0.06 | +50.0% | 13.93 | -4.8% | +0.8% | +0.6% | -2.2% | -3.3% | -6.5% | — |
| Oct 30, 2025 | AMC | -0.03 | 0.03 | +200.0% | 16.33 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% | — |
| Jul 31, 2025 | AMC | -0.06 | 0.02 | +133.3% | 10.58 | +13.2% | +30.2% | +40.5% | +45.0% | +43.7% | +40.8% | — |
| May 1, 2025 | AMC | -0.12 | -0.23 | -91.7% | 11.06 | +4.0% | +8.5% | +8.3% | +10.0% | +12.6% | +15.2% | — |
| Feb 26, 2025 | AMC | -0.19 | -0.23 | -21.1% | 11.06 | -5.1% | +9.6% | +13.3% | +10.9% | +6.1% | +3.4% | — |
| Oct 30, 2024 | AMC | -0.27 | -0.28 | -3.7% | 5.62 | +24.2% | +39.7% | +44.3% | +48.8% | +52.7% | +57.8% | — |
| Jul 31, 2024 | AMC | -0.26 | -0.29 | -11.5% | 10.10 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% | — |
| May 7, 2024 | AMC | -0.33 | -0.34 | -3.0% | 13.58 | -14.3% | -21.9% | -16.5% | -15.2% | -18.0% | -20.0% | — |
| Feb 27, 2024 | AMC | -0.28 | -0.37 | -32.1% | 15.34 | -5.7% | -8.9% | -12.5% | -12.5% | -12.1% | -14.1% | — |
| Nov 6, 2023 | AMC | -0.30 | -0.35 | -16.7% | 10.31 | +6.7% | +5.2% | +2.5% | -1.8% | -1.1% | -3.6% | — |
| Aug 3, 2023 | AMC | -0.30 | -0.43 | -43.3% | 16.88 | +0.7% | -5.6% | -4.4% | -9.1% | -11.0% | -11.4% | — |
| May 4, 2023 | AMC | -0.32 | -0.40 | -25.0% | 14.66 | +4.0% | +3.4% | +1.3% | +4.1% | +6.4% | +2.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9 | Stifel | Maintains | Buy → Buy | — | $12.23 | $11.99 | -2.0% | +5.2% | +2.3% | +3.5% | +2.2% | +0.4% |
| Jan 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.65 | $21.47 | -5.2% | -22.3% | -27.4% | -29.6% | -22.9% | -21.7% |
| Jan 12 | Needham | Maintains | Buy → Buy | — | $22.65 | $21.47 | -5.2% | -22.3% | -27.4% | -29.6% | -22.9% | -21.7% |
| Jan 7 | Barclays | Maintains | Overweight → Overweight | — | $21.79 | $22.02 | +1.1% | +0.8% | +4.1% | +3.9% | -19.3% | -24.5% |
| Nov 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $19.80 | $19.75 | -0.3% | +2.2% | +4.6% | +4.8% | +2.0% | -0.3% |
| Nov 3 | Barclays | Maintains | Overweight → Overweight | — | $18.99 | $18.85 | -0.7% | +1.6% | +2.3% | +3.8% | +2.7% | +4.3% |
| Oct 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.33 | $20.02 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% |
| Oct 31 | Canaccord Genuity | Maintains | Buy → Buy | — | $16.33 | $20.02 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% |
| Oct 31 | Stifel | Maintains | Buy → Buy | — | $16.33 | $20.02 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% |
| Oct 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $16.33 | $20.02 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $16.33 | $20.02 | +22.6% | +16.3% | +18.1% | +18.9% | +20.8% | +19.5% |
| Oct 16 | Wells Fargo | Maintains | Overweight → Overweight | — | $13.99 | $14.13 | +1.0% | +1.9% | +6.4% | +10.8% | +10.8% | +12.0% |
| Aug 4 | Barclays | Maintains | Overweight → Overweight | — | $13.77 | $13.98 | +1.5% | +8.0% | +11.4% | +10.4% | +8.2% | +8.7% |
| Aug 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.58 | $11.98 | +13.2% | +30.2% | +40.5% | +45.0% | +43.7% | +40.8% |
| May 2 | Needham | Maintains | Buy → Buy | — | $11.06 | $11.50 | +4.0% | +8.5% | +8.3% | +10.0% | +12.6% | +15.2% |
| May 2 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.06 | $11.50 | +4.0% | +8.5% | +8.3% | +10.0% | +12.6% | +15.2% |
| Apr 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.75 | $10.01 | +2.7% | +4.4% | +1.6% | +4.9% | +8.3% | +9.1% |
| Feb 27 | Needham | Maintains | Buy → Buy | — | $11.06 | $10.50 | -5.1% | +9.6% | +13.3% | +10.9% | +6.1% | +3.4% |
| Feb 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.06 | $10.50 | -5.1% | +9.6% | +13.3% | +10.9% | +6.1% | +3.4% |
| Jan 22 | Barclays | Maintains | Overweight → Overweight | — | $11.61 | $11.57 | -0.3% | -2.0% | +0.5% | -5.2% | -4.1% | -1.4% |
| Jan 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.88 | $11.04 | +1.5% | +2.2% | +4.3% | +3.8% | +6.3% | +6.7% |
| Jan 13 | Needham | Maintains | Buy → Buy | — | $9.97 | $10.40 | +4.3% | +9.1% | +11.5% | +13.8% | +13.2% | +16.0% |
| Nov 19 | Barclays | Maintains | Overweight → Overweight | — | $8.52 | $8.52 | +0.0% | +12.3% | +16.5% | +19.8% | +18.1% | +12.9% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $5.62 | $6.98 | +24.2% | +39.7% | +44.3% | +48.8% | +52.7% | +57.8% |
| Oct 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.62 | $6.98 | +24.2% | +39.7% | +44.3% | +48.8% | +52.7% | +57.8% |
| Sep 3 | Lake Street | Maintains | Buy → Buy | — | $6.90 | $6.86 | -0.6% | -1.4% | -2.2% | -3.6% | -7.0% | -18.1% |
| Aug 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $6.85 | $6.88 | +0.4% | +0.7% | -0.7% | -1.5% | -2.9% | -6.3% |
| Aug 22 | Needham | Maintains | Buy → Buy | — | $5.68 | $5.86 | +3.2% | +0.2% | +1.1% | +4.6% | +11.3% | +10.0% |
| Aug 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $10.10 | $7.90 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $10.10 | $7.90 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% |
| Aug 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.10 | $7.90 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% |
| Aug 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.10 | $7.90 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $10.10 | $7.90 | -21.8% | -34.3% | -37.6% | -35.1% | -35.7% | -39.6% |
| Jul 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.91 | $10.81 | -0.9% | -0.4% | +0.0% | -8.3% | -9.4% | -7.4% |
| Jul 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $11.25 | $11.31 | +0.5% | +1.5% | +5.5% | +4.4% | -1.7% | -1.4% |
| Jul 11 | Stifel | Maintains | Buy → Buy | — | $10.77 | $10.92 | +1.4% | +1.8% | +4.5% | +6.0% | +10.2% | +9.0% |
| May 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.58 | $11.64 | -14.3% | -21.9% | -16.5% | -15.2% | -18.0% | -20.0% |
| May 8 | Needham | Maintains | Buy → Buy | — | $13.58 | $11.64 | -14.3% | -21.9% | -16.5% | -15.2% | -18.0% | -20.0% |
| Mar 28 | Needham | Maintains | Buy → Buy | — | $13.80 | $13.88 | +0.6% | -0.1% | +1.2% | -2.2% | -2.2% | -3.0% |
| Mar 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $14.15 | $14.65 | +3.5% | -2.6% | -3.0% | -6.6% | -3.8% | -5.2% |
| Mar 20 | Needham | Maintains | Buy → Buy | — | $14.15 | $14.65 | +3.5% | -2.6% | -3.0% | -6.6% | -3.8% | -5.2% |
| Mar 13 | Needham | Maintains | Buy → Buy | — | $13.33 | $13.45 | +0.9% | +3.5% | +0.1% | -1.8% | +1.4% | +6.2% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.42 | $13.60 | +1.3% | +0.5% | -1.8% | -3.0% | -3.9% | -4.6% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $15.34 | $14.46 | -5.7% | -8.9% | -12.5% | -12.5% | -12.1% | -14.1% |
| Jan 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $15.44 | $15.70 | +1.7% | +3.0% | +3.6% | +3.0% | +4.5% | +5.2% |
| Dec 19 | Needham | Maintains | Buy → Buy | — | $13.55 | $13.94 | +2.9% | +6.7% | +7.0% | +10.9% | +11.4% | +13.2% |
| Nov 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $9.94 | $10.36 | +4.2% | +6.9% | +12.7% | +14.5% | +10.7% | +14.4% |
| Nov 7 | Stifel | Maintains | Buy → Buy | — | $10.31 | $11.00 | +6.7% | +5.2% | +2.5% | -1.8% | -1.1% | -3.6% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $10.31 | $11.00 | +6.7% | +5.2% | +2.5% | -1.8% | -1.1% | -3.6% |
| Aug 4 | Needham | Maintains | Buy → Buy | — | $16.88 | $16.99 | +0.7% | -5.6% | -4.4% | -9.1% | -11.0% | -11.4% |
No insider trades available.
8-K · 1.02
!! High
Alphatec Holdings, Inc. -- 8-K 1.02: Material Agreement Terminated
I need more information to provide a specific analysis. The summary "Terminated Prior Credit" lacks details about the termination reason (breach, mutual agreement, expiration, or regulatory) and the credit facility's size/importance, making it impossible to assess investor implications accurately.
May 5
8-K · 5.02
!!! Very High
Alphatec Holdings, Inc. -- 8-K 5.02: Executive Change
Alphatec Holdings lost a board member and Compensation Committee participant, potentially affecting executive pay oversight and governance structure at the spine surgery company.
Mar 3
8-K
Alphatec Holdings, Inc. -- 8-K Filing
Alphatec Holdings reported 25% full-year 2025 revenue growth to $764 million with expanded profit margins, guiding 2026 revenue toward $890 million, demonstrating strong operational momentum.
Feb 24
Data updated apr 24, 2026 7:27pm
· Source: massive.com